NTNX Stock: BUY Call - VMware Displacement +34% EPS Beat Q3 FY2026

WB Stock: BUY Call - EPS Halves on Investment Swings as Operations Hold Q1 2026

Weibo Q1 2026 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: BUY (4/5 conviction, STRONG) - CURRENT @ $7.84 - BUY - BUY below $7.50 with $6.00 stop - AVOID above $12.00 TRIGGER: Two quarters of advertising revenue growth accelerating OR a formal buyback/dividend expansion WINDOW: Through Q3 2026 earnings (late November 2026) TRACKER: chargedalpha.com/calls/WB WALL STREET CONSENSUS - Ratings: 3 Strong Buy / 4 Buy / 9 Hold / 1 Sell / 0 Strong Sell - HOLD - Median 12-month price target: $11.50 (range $8 - $16) - Charged Alpha vs consensus: MORE BULLISH THESIS Weibo trades around four times earnings with cash and short-term investments larger than its market cap and a twenty-five percent free-cash-flow yield, while operating profit is flat and revenue grew six percent -- a deep-value setup where the GAAP EPS drop is investment-portfolio noise. Bull lever: A genuine China ad-market recovery plus a buyback funded by the cash pile could re-rate a four-times-earnings stock back toward the peer group, with substantial upside from this eight-dollar level. Key risk: Advertising is roughly eighty percent of revenue and highly China-macro sensitive; if ad demand rolls over, or if user engagement keeps losing share to short-video platforms, the cheap multiple can stay cheap for years. QUALITY CHECK - Management quality grade: B (Long-tenured team with disciplined mid-twenties operating margins through the cycle, but the heavy investment-portfolio exposure injects GAAP-EPS volatility, and capital return has been inconsistent.) - Earnings quality grade: B+ (Core earnings are backed by real cash -- trailing free cash flow far exceeds the seasonally weak quarter -- and the GAAP-to-operating gap is transparent fair-value movement, not aggressive accruals.) CHAPTERS 0:00 Hook 0:14 Year in One Chart 0:42 The Print 1:26 Earnings Bridge 2:03 The Trend 2:46 The Revenue Mix 3:22 The FCF Bridge 4:06 Margin Quality 4:45 Guidance & The Narrative Diff 5:44 Catalyst Calendar 6:18 Peer Dot-Plot 7:00 Valuation Triangle 7:35 Management & Earnings Quality 8:44 The Call - Verdict (price-aware + consensus) 9:27 The Call - Supporting Evidence KEY METRICS - Q1 2026 - Revenue: $0.42B (YoY +6.2%, beat est by +1.0%) - EPS: $0.15 (vs $0.27 est, beat -44.4%) - Operating margin: 26.3% - Free cash flow: $0.03B (7.0% margin) Weibo reported Q1 2026 with revenue up about 6 percent year over year to $421 million and operating profit essentially flat at $111 million -- yet GAAP EPS fell to $0.15 from $0.45 a year ago, a 67 percent drop driven almost entirely by non-operating fair-value changes on its investment portfolio rather than any operating deterioration. The stock trades near $7.84, about four times earnings, with cash and short-term investments of roughly $2.6 billion that exceed the entire $1.9 billion market cap, and a trailing free-cash-flow yield around 25 percent. The debate is whether China's advertising market recovers; the margin of safety is unusually large. NARRATIVE DIFF - what changed in management tone - Prior call: "We remain focused on enhancing user engagement and improving advertising monetization efficiency as the macro environment gradually stabilizes." - This call: "Our first-quarter operating results were resilient, with advertising revenue returning to year-over-year growth; reported net income reflects non-operating fair-value changes on our investment portfolio rather than a change in the underlying business." - Tone shift: Management moved from a cautious wait-for-the-macro tone to explicitly pointing investors past the volatile GAAP net income toward resilient operating results and the return of advertising growth. DATA SOURCES - FMP (financialmodelingprep.com) - Weibo Q1 2026 press release + earnings call DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in WB. Do your own research before any investment decision. #WB #Weibo #earnings #investing #stocks #ChargedAlpha

UVV Stock: HOLD Call - $43M Loss On A One-Time Impairment Q4 FY2026

Universal Corporation Q4 FY2026 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: HOLD (3/5 conviction, MODERATE) - CURRENT @ $51.16 -> HOLD - ADD below $48.00 with $42.00 stop - AVOID above $62.00 TRIGGER: A Q1 FY27 print showing dark air-cured oversupply easing and adjusted EPS back positive, OR a dip under $48 that lifts the yield above 6.8% WINDOW: Through Q1 FY2027 earnings (August 2026) WALL STREET CONSENSUS - Ratings: 0 Strong Buy / 1 Buy / 2 Hold / 0 Sell / 0 Strong Sell -> HOLD - Median 12-month PT: $60.00 (range $55 - $70) THESIS Universal Corporation is the world's largest leaf-tobacco merchant and a 56-year Dividend King, with a small but growing plant-based Ingredients segment. Bull lever: Net sales rose 2 percent and free cash flow stayed positive; the $43M loss is a non-cash $41M goodwill impairment plus one-time tobacco write-downs, and the 6.4 percent dividend yield is funded from crop-cycle cash flow. Key risk: Even adjusted, the quarter was a loss on dark air-cured oversupply; secular leaf-tobacco decline and a dividend that exceeds single-year EPS make coverage the central question. KEY METRICS - Q4 FY2026 - Net sales: $715.2M (+2% YoY) - GAAP diluted EPS: $-1.73 (vs +$0.37 a year ago) - Adjusted EPS: $-0.46 (vs +$0.80 a year ago) - Net loss: $-43.3M, driven by a $41.1M non-cash goodwill impairment (Shank's/Ingredients) + $52M tobacco inventory write-downs - Dividend: 56th consecutive annual increase, $3.28 annualized (~6.4% yield) - Stock reaction: fell 7.4% to a fresh 52-week low DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in UVV. #UVV #UniversalCorp #tobacco #dividendking #agribusiness #earnings #investing #stocks #ChargedAlpha #dividends

PLUS Stock: BUY Call - Net Sales Up 21% Q4 FY2026

ePlus inc. Q4 FY2026 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: BUY (4/5 conviction, STRONG) - CURRENT @ $88.65 -> BUY - BUY below $85.00 with $62.00 stop - AVOID above $110.00 TRIGGER: Q1 FY27 print confirms mid-single-digit-plus growth AND gross margin holds near 25 percent WINDOW: 12-18 months - services-mix shift and AI-infrastructure reselling demand WALL STREET CONSENSUS - Ratings: 0 Strong Buy / 3 Buy / 2 Hold / 0 Sell / 0 Strong Sell -> BUY - Median 12-month PT: $94.00 (range $85 - $105) THESIS ePlus is a cash-rich IT-solutions reseller and services provider compounding on A.I., cloud and networking demand, growing net sales twenty one percent with earnings up fifty three percent. Bull lever: A simpler, services-richer model after the financing divestiture, record gross billings, a net-cash balance sheet, and steady capital return via an eight percent dividend hike and buybacks. Key risk: Gross margin eased to twenty four point six percent on richer product mix; IT reselling is cyclical and exposed to a memory-supply shortage; the FY27 guide is only mid-single-digit growth. KEY METRICS - Q4 FY2026 (continuing operations) - Net sales: $576.2M (+20.6% YoY) - Diluted EPS: $0.78 (+52.9% YoY) - Product net sales: $466.2M, +25% YoY - Services revenues: $110.0M, +4.9% YoY - Gross billings: $881.0M (record run rate) - Adjusted EBITDA: $40.1M, +40% YoY - Operating income: $30.9M, +64% YoY - Gross margin: 24.6% (richer product mix) - Cash $410.8M / net cash; dividend raised 8% to $0.27 - FY27 guide: mid-single-digit growth in net sales, gross profit, adj EBITDA DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in PLUS. #PLUS #ePlus #earnings #investing #stocks #ChargedAlpha #ITsolutions #VAR #AI #cloud

HQY Stock: BUY Call - EPS +32% on HSA Custodial Tailwind Q1 FY2027

HealthEquity, Inc. Q1 FY2027 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: BUY (4/5 conviction, STRONG) - CURRENT @ $90.52 -> BUY - BUY below $88.00 with $72.00 stop - AVOID above $120.00 TRIGGER: Q2 FY27 print confirms double-digit custodial revenue growth AND adjusted EBITDA margin holds near 40 percent WINDOW: 12-18 months - FY27 earnings compounding plus a re-rate toward the $110 target WALL STREET CONSENSUS - Ratings: 1 Strong Buy / 24 Buy / 1 Hold / 1 Sell / 0 Strong Sell -> BUY - Median 12-month PT: $110.00 (range $89 - $125) THESIS HealthEquity is the largest HSA custodian in the United States, with over eleven million total accounts and a custodial cash base that earns net interest income, compounding GAAP earnings in the low-thirties percent year over year. Bull lever: Custodial revenue, the net interest income on HSA cash, grew double digits and operating margin hit twenty nine percent; the company redeemed its convertible debt to a net-cash balance sheet while compounding accounts. Key risk: Custodial net interest income is rate-sensitive; a sharp rate-cut cycle compresses yields, and headline revenue growth is mid-single-digit-plus, slower than richer-multiple HCM peers. KEY METRICS - Q1 FY2027 - Revenue: $354.6M (+7.2% YoY) - Diluted EPS: $0.82 (vs $0.74 est, +32% YoY) - Net income: +28.8% YoY - GAAP Operating margin: 29.0% - Free Cash Flow: $97.2M; FCF margin 27.4% - HSA accounts and custodial cash drive recurring service, custodial and interchange revenue - Custodial net interest income is the rate-sensitive swing factor on the model DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in HQY. #HQY #HealthEquity #earnings #investing #stocks #ChargedAlpha #HSA #Fintech

ASAN Stock: BUY Call - Loss Halved, FCF Tripled Q1 FY2027

Asana Q1 FY2027 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: BUY (3/5 conviction, MODERATE) - CURRENT @ $6.66 -> BUY - BUY below $6.50 with $5.20 stop - AVOID above $11.00 TRIGGER: Q2 print confirms revenue holds above $207M AND non-GAAP operating margin expands again WINDOW: 12-24 months - durable FCF profitability and an AI Studio re-rate WALL STREET CONSENSUS - Ratings: 2 Strong Buy / 3 Buy / 9 Hold / 2 Sell / 0 Strong Sell -> HOLD - Median 12-month PT: $12.00 (range $7 - $18) THESIS Asana is a founder-led work-management SaaS where the operating loss has collapsed from negative 23 percent of revenue to negative 7 percent and free cash flow has tripled to 37 million dollars in a single year. Bull lever: Free cash flow margin reached 18 percent and the founder Dustin Moskovitz, who owns a huge stake, keeps buying stock near multi-year lows at one and a half times sales. Key risk: Revenue growth has decelerated to single digits and net revenue retention has softened toward the high nineties, so the durable-growth question is unresolved. KEY METRICS - Q1 FY2027 - Revenue: $205.1M (+9.5% YoY) - Non-GAAP EPS: $0.05 (vs $0.03 est) - GAAP net loss: -$14.4M (narrowed from -$40.0M a year ago) - GAAP operating margin: -7.4% (vs -23.4% YoY, +1600 bps) - Free cash flow: $37.4M (18.2% margin) vs $4.0M a year ago - Net cash position; founder Dustin Moskovitz adding shares DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in ASAN. #ASAN #Asana #earnings #investing #stocks #ChargedAlpha #SaaS #AI